Clinicians' knowledge, beliefs and acceptance of intravenous-to-oral antibiotic switching, hospital Pulau Pinang

Medical Journal of Malaysia

Volumn 67, Issue 2, 2012, Pages 190-198

  Lee, S L ^a   Azmi, Sarriff ^a   Wong, P S ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Acceptace; Antibiotic switching practice guidelines; Antibiotic switching therapy; Clinicians beliefs; Knowledge

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CHECKLIST; CROSS-SECTIONAL STUDY; DRUG ADMINISTRATION ROUTE; FEMALE; HEALTH BELIEF; HEALTH CARE PERSONNEL; HUMAN; INFECTION; KNOWLEDGE; MALE; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; QUESTIONNAIRE; VALIDATION PROCESS; ATTITUDE TO HEALTH; CHI SQUARE DISTRIBUTION; CLINICAL PRACTICE; DECISION MAKING; INTRAVENOUS DRUG ADMINISTRATION; MALAYSIA; NONPARAMETRIC TEST; ORAL DRUG ADMINISTRATION; STATISTICS;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DECISION MAKING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFUSIONS, INTRAVENOUS; MALAYSIA; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC;

EID: 84866449336     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Mohd Hanafiah R, Gan YL, Lee CL. Antibiotic purchase at Hospital Pulau Pinang. 2009
2. Wong-Beringer A, Nguyen K, Razeghi J. Implementing a program for switching from i.v. to oral antimicrobial therapy. Am J Health Syst Pharm 2001; 58: 1146-9.
3. Wetzstein G. Intravenous to oral (IV:PO) Anti-infective Conversion Therapy 2000: Available from: http://www.medscape.com/viewarticle/408980.
4. Fine M, Stone R, Lave J, Hough L, Obrosky D, Mor M, et al. Implementation of an evidence-based guideline to reduce duration of intravenous antibiotic therapy and length of stay for patients hospitalized with community-acquired pneumonia: A randomized controlled trial. Am J Health Syst Pharm 2003; 115: 343-51.
5. Gunten V, Amos V, Sidler A, Beney J, Troillet N, Reymond J-P. Hospital pharmacists' reinforcement of guidelines for switching from parenteral to oral antibiotics: a pilot study. Pharm World Sci. 2003; 25(2): 52-5.
6. Hunter K, Dormaier G. Pharmacist-managed intravenous to oral step-down program. Clin Ther 1995; 17: 534-40.
7. Laing R, Mackenzie A, Shaw H, Gould I, Doughlas J. The effect of intravenous-to-oral switch guidelines on the use of parenteral antimicrobials in medical wards. J Antimicrob Chemother. 1998; 42: 107-11.
8. McLaughlin C, NB, Boyter A, Fenelon C, Fox J, Seaton R. Pharmacy-implemented guidelines on switching from intravenous to oral antibiotics: An intervention study. QJM. 2005; 98: 745-52.
9. Mertz D, Koller M, Haller P, Lampert M, Plagge H, Hug B, et al. Outcomes of early switching from intravenous to oral antibiotics on medical wards. J Antimicrob Chemother. 2009; 64: 188-9.
10. Omidvari K, Boisblanc B, Karam G, Nelson S, Haponik E, Summer W. Early transition to oral antibiotic therapy for community-acquired pneumonia:duration of therapy, clinical outcomes, and cost analysis. Respir Med. 1998; 92: 1032-9.
11. Ramirez J, Vargas S, Ritter G, Brier M, Wright A, Smith S, et al. Early switch from intravenous to oral antibiotics and early hospital discharge: A prospective observational study of 200 consecutive patients with community-acquired pneumonia. Arch Intern Med. 1999; 159: 2449-54.
12. Rwalins M, Cerbe L. Intravenous to oral (IV to PO) antimicrobial switching. ASA Newsletter 2006. p. 1-7.
13. Senn L, Burnand B, Francioli P, Zanetti G. Improving appropriateness of antibiotic therapy: Randomised trial of an intervention to foster reassessment of prescription after 3 days. J Antimicrob Chemother. 2004; 53: 1062-7.
14. Servinc F, Prins J, Koopmans R, Langendijk J, Bossuyt P, Danjert J, et al. Early switch from intravenous to oral antibiotics: guidelines in a large teaching hospital. J Antimicrob Chemother. 1999; 43: 601-6.
15. Vogtlander N, Kasteren M, Natsch S, Kullberg B, Hekster Y, Meer J. Improving the process of antibiotic therapy in daily practice: Interventions to optimise timing, dosage adjustment to renal function and switch therapy. Arch Intern Med. 2004; 164: 1206-12.
16. Halm E, Switzer G, Mittman B, Walsh M, Chang C, FIne M. What factors influence physicians' decisions to switch from intravenous to oral antbiotics for community acquired pneumonia? J Gen Intern Med. 2001; 16: 599-605.
17. Kuper K. Intravenous to oral therapy conversion Bethesda: Am J Health Syst Pharm; 2008. Available from: www.ashp.org/DocLibrary/MemberCenter/ClinicalSpecialistandScientists/IVtoPO.pdf.
18. Fine M, Smith M, Carson C, Mutha S, Sankey S, Weissfeld L, et al. Prognosis and outcomes of patients with community-acquired penumonia. JAMA. 1996; 275(2): 134-41.
19. Halm E, Fine M, Marrie T, Coley C, Kapoor W, Obrosky D, et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia. JAMA. 1998; 279(18): 1452-7.
20. Halm E, Causino N, Blumenthal D. Is gatekeeping better than traditional care? JAMA. 1997; 278(20): 1677-81.
21. Cacares V, Stange K, Kikano G, Zyzanski S. The clinical utility of a day of hospital observation after switching from intravenous to oral antibiotic therapy in the treatment of pyelonephritis [Abstract]. J Fam Pract. 1994; 39: 307-16.
22. Rhew D, Hackner D, Henderson L, Ellrodt A, Weingarten S. The clinical benefit of in-hospital observation in 'low-risk' pneumonia patients after conversion from parenteral to oral antimicrobial therapy. Chest. 1998; 113: 142-6.
23. Siegel R, Halpern N, Almenoff P, Cashin R, Lee A, Greene J. A prospective randomised study of inpatient IV antibiotics for community-acquired pneumonia: The optimal duration of therapy. Chest. 1996; 110: 965-71.
24. Angel J, O'Brien W, Finan M, Morales W, Lake M, Knuppel R. Acute pyelonephritis in pregnancy: A prospective study of oral versus intravenous antibiotic therapy [Abstract]. Obstet Gynecol 1990; 76(1): 28-32.
25. Cooke J, Cairns C, Tillotson G, Conner S, Lewin S, Tredree R, et al. Comparative clinical, microbiologic, and economic audit of the use of oral ciprofloxacin and parenteral antimicrobials [Abstract]. Ann Pharmacother. 1993; 27: 785-9.
26. Hackam D, NC, YK, DR D, DV, JC M, et al. Bioavailability of oral ciprofloxacin in early postsurgical patients. Arch Surg. 1998; 133: 1221-5.
27. Hoppe J. Rational prescribing of antibacterials in hospitalised children [Abstract]. Pharmacoeconomics. 1996; 10: 575-93.
28. Drew R. Programs promoting timely sequential antimicrobial therapy: an American perspective. J Infect. 1998; 37(Supp 1): 3-9.
29. Cunha B. Intravenous to oral antibiotic switch therapy. Postgrad Med. 1997; 101: 111-23.
30. Davey P, D N. Sequential antibiotic therapy: The right patient, the right time and the right outcome. J Infect. 1998; 37(1): 37-44.
31. Halm E, Atlas S, Borowsky L, Benzer T, Singer D. Change in physician knowledge and attitudes after implementation of a pneumonia practice guideline. J Gen Intern Med. 1999; 14: 688-94.
32. Halm E, Atlas S, Borowsky L, Benzer T, Metlay J, Chang Y, et al. Understanding physician adherence with a pneumonica practice guideline. Arch Intern Med. 2000; 160: 98-104.